Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2024

Jan 24, 2024

284_dirs_2024-01-24_3bbd8ecf-5b85-4a6c-ba04-f01d5b80fea9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2024-01-22

Reporting Person: Klobuchar Michael A (EVP - Chief Strategy Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-01-22 Common Stock A 3896 $119.43 Acquired 23098.138 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 6.292 Indirect
Common Stock 6.292 Indirect
Common Stock - 401(k) Plan 862.033 Indirect
Common Stock - 401(k) Plan 693.8675 Indirect

Footnotes

F1: Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/21. Performance shares were paid out at 161 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2023.

F2: Holdings include shares acquired in dividend reinvestment transactions.

F3: Includes shares acquired and dividends earned through January 8, 2024 in the Merck U.S. Savings Plan, a 401(k) plan.